InvestorsHub Logo
Followers 790
Posts 38997
Boards Moderated 15
Alias Born 06/20/2009

Re: BigBadWolf post# 44440

Wednesday, 11/24/2021 2:07:12 PM

Wednesday, November 24, 2021 2:07:12 PM

Post# of 64592
Globally the $TSOI science is needed, so combined w/ the below phrasing/wording used would have had a majority of the investing public believing that T. Dixon & team would have achieved more forward traction as to date. W/ more of a sense of Urgency that seems to be a bit lacking. Especially considering the subsequent follow up PR.

"The extremely promising preclinical data we are generating, as well as the previously published double blind FDA clinical trial and most recently, FDA clearance to enter Phase III, strongly supports the rationale to file for Emergency Use Authorization" said Dr. James Veltmeyer, Chief Medical Officer of the Company. "As a practicing physician, myself and my colleagues are eager to begin using these cells and potentially saving lives


"We are thankful to our Advisory Board, which includes Dr. Francesco Marincola, World Wide Head of Cell Therapy Research for Gilead, and Dr. Santosh Kesari, Principle Investigator on other stem cell trials for COVID-19, for bringing decades of national and international expertise in dealing with regulatory bodies in fast-tracking approval of cellular and gene therapies in helping us to make this monumental decision" said Timothy Dixon, President and CEO of Therapeutic Solutions International. "Given the urgent nature of the ongoing pandemic, and the early suggestions that our cells are effective against the delta variant, we are exploring and pursuing all possible avenues to bring JadiCells to the patients that need them now.



https://www.prnewswire.com/news-releases/therapeutic-solutions-international-prepares-to-apply-for-emergency-use-authorization-eua-for-its-fda-phase-iii-covid-19-stem-cell-therapy-jadicell-301355728.html

https://www.prnewswire.com/news-releases/therapeutic-solutions-international-engages-venvalo-group-to-oversee-jadicell-covid-19-phase-iii-clinical-trial-and-emergency-use-authorization-eua-process-301373258.html


Alpha Male always Caribbean Wolf Pack Strong The Society of Slayers...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News